Objective: Hyaluronan (HA) is an important constituent of the extracellular matrix and is known to regulate cellular events through binding to CD44 and the receptor for HA-mediated motility (RHAMM). Here we investigated the role of these receptors and the signaling pathways involved in HA-mediated effects in arterial smooth muscle cells (ASMC). Methods: Effects of high-molecular weight HA (1 to 5 mg/ml) were analyzed in cultured ASMC from rat aorta. Results: HA promoted actin stress fiber and lamellipodia formation and dose-dependently induced ASMC migration without effect on proliferation. Pull-down assay of Rho protein activity indicated that HA activated RhoA and Rac. HA-induced ASMC migration was not affected by the RhoA inhibitor Tat-C3 (10 μg/ml), the Rho kinase inhibitor Y-27632 (10 μM) and blocking anti-CD44 antibody ,but was reduced by the non-selective Rho protein inhibitor simvastatin (10 μM), the Rac inhibitor LT-toxin (1 μg/ml), small interfering RNA (siRNA) targeting Rac and the phosphatidyl inositol 3-kinase (PI3K) inhibitor LY294002 (25 μM), which also blocked HA-induced Rac activation. CD44 knockdown by siRNA inhibited HA-mediated RhoA activation without effect on ASMC migration. In contrast, siRNA targeting RHAMM inhibited both HA-induced migration and Rac activation. Conclusions: High-molecular weight HA independently activates RhoA and Rac through CD44 and RHAMM, respectively. HA-induced migration depends exclusively on RHAMM-mediated PI3K-dependent Rac activation.
Introduction
Vascular proliferative disorders such as atherosclerosis, restenosis or allograft rejection are characterized by arterial smooth muscle cells (ASMC) proliferation and migration associated with marked changes into extracellular matrix (ECM) [1] . Hyaluronan (HA) is a high molecular weight polysaccharide (1000-10,000 kDa) widely distributed in ECM of a variety of tissues including the arterial wall. Studies have clearly shown that HA not only accumulates at different stages in atherosclerosis and restenosis, promotes atherosclerosis, but also regulates ASMC functions including proliferation, migration and secretion [2] [3] [4] . HA could also be located inside the cells and some HA effects have been ascribed to intracellular HA [5, 6] .
Numerous studies that analyzed in vitro the biological effects of HA in various cell types have yielded to mixed results. In addition to the different cell types used, several influences directly related to the complexities of HA binding, HA receptors and HA size could underlie the observed Cardiovascular Research 72 (2006) 339 -348 www.elsevier.com/locate/cardiores variability [7] . The biological functions of HA are essentially mediated by cell surface HA receptors or hyaladherins. Among hyaladherins, CD44 and the receptor for HAmediated motility (RHAMM) have been identified in ASMC [8] . CD44 comprises a large family of transmembrane glycoproteins that exhibit extensive molecular heterogeneity. The CD44 ectodomain is responsible of the binding of HA, and the cytoplasmic domain regulates specific signaling and interacts with cytoskeletal proteins such as ankyrin or ERM (ezrin, radixin, and moesin) [8, 9] . RHAMM is an 85-kDa protein expressed in most tissues, distributed in multiple compartments including cell surface, cytoskeleton, mitochondria and cell nucleus [8] . RHAMM binds HA and also acts as a microtubule-associated protein interacting with the actin [8, 10] . The relative contribution of the two types of HA receptors and the intracellular signaling pathways involved in HA-mediated effects in ASMC remain unknown.
The small G proteins of the Rho family are identified as tightly regulated molecular switches that cycle between an inactive GDP-bound and an active GTP-bound conformation that interacts with downstream targets (effectors) to elicit cellular responses [11] . The best characterized members of the Rho protein family, RhoA, Rac and Cdc42, are recognized as major regulators of the actin cytoskeleton [11] . A large body of evidence has now been obtained regarding the important functions of Rho proteins in the vasculature [12, 13] . Rho protein signaling has been demonstrated to be a critical mechanism for controlling vascular smooth muscle differentiation [14, 15] , proliferation [16, 17] , and migration [18, 19] . In addition, mainly through their effect on actin cytoskeleton organization, Rho proteins regulate essential cell functions such as adhesion, cytokinesis and transcription. In mammary epithelial cells and in breast tumor cells, it has been shown that HA binding to CD44 promotes activation of Rac and that the association of CD44 V3 isoform to RhoA is involved in metastatic tumor cell migration [20] [21] [22] .
In this study we investigated the role of the HA receptors CD44 and RHAMM, and the involvement of Rho protein signaling in the effects mediated by high-molecular weight HA in ASMC. We show that HA stimulates the actin cytoskeleton organization and dose-dependently induces ASMC migration. Our results demonstrate that HA activates two independent signaling pathways in ASMC and that although HA binding to CD44 induces RhoA activation, HA-induced migration exclusively depends on phosphatidyl inositol 3-kinase (PI3K)-and Rac-dependent signaling pathway downstream to RHAMM activation.
Materials and methods

Cell culture
Rat ASMC were isolated from aorta by enzymatic dissociation and cultured as previously described [23] . Only smooth muscle cells at passage 3 were used in this study. The investigation conforms with the Guide for the Care and Use 
Vascular smooth muscle cells migration assays
For in vitro wound healing assay, a sterile pipette tip was used to make a 0.5-mm-wide wound by streaking across a monolayer of ASMC serum-starved for 24 h. Multiple photographs of the wound were taken at various time postwounding in serum-free medium (control) or in the presence of various HA concentrations. The areas of cell recoverage were determined with image analysis software (Metamorph, Universal Imaging Corp, West Chester, PA). The percentage of cellular recoverage area to the whole wound area was measured to evaluate migration. The effect of various agents such as Tat-C3, Y-27632, LY 294002 and blocking CD44 antibody were analyzed by addition to culture medium 24 h before adding HA. For Boyden chamber assay [24] , ASMC were trypsinized and washed in serum-free DMEM before plating into a 12-well Transwell plate (12 mm diameter, 8 μm pore size, Corning Incorporated Costar) at 5 × 10 4 cells per/ well. DMEM containing various concentrations of HA (1-5 mg/ml) was placed in the lower chamber and ASMC were allowed to migrate for 8 h at 37°C. After incubation, the filter was removed, and ASMC on the upper side of the filter were scraped off. ASMC that had migrated to the lower side of the filter were fixed in methanol at 4°C for 15 min, stained with Toluidin blue and counted under a microscope for quantification of ASMC migration. Migration was expressed as the number of cells that had migrated per high-power field (× 400).
Actin staining
Serum-starved (24 h) ASMC, stimulated or not with HA, were fixed for 30 min in 4% paraformaldehyde, permeabilized for 10 min in 0.5% Triton X-100, and then rinsed in phosphate-buffered saline (PBS). Polymerized F-actin was stained with FITC-conjugated phalloidin (5 μg/ml, 45 min at room temperature). After washing with PBS, coverslips were mounted on a glass slide and examined with a fluorescence microscope (Eclipse E-600, Nikon, Champigny-sur-Marne, France). Images were collected with a cool-SNAP camera (Princeton Instruments, Evry, France) and stored for analysis (Metamorph, Universal Imaging Corp).
Western blot analysis
Serum-starved (24 h) ASMC, stimulated or not with HA, were harvested and homogenized in lysis buffer containing 50 mM Tris, pH 7.2, 500 mM NaCl, 10 mM MgCl 2 , 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, protease inhibitor cocktail (Sigma), phosphatase inhibitor cocktail (Sigma). Nuclei and unlysed cells were removed by low speed centrifugation at 10,000×g for 15 min at 4°C.
Proteins were resolved on SDS-PAGE and transferred to nitrocellulose membranes, which were incubated with specific antibodies for detection of RhoA, Rac, CD44, RHAMM, β-actin, phosphorylated P21-activated kinase 1 (PAK1) (used to monitor the activation of the Rac/PAKs signalling) and PAK1. Immunoreactive bands were visualized using horseradish peroxidase conjugated secondary antibody and subsequent ECL detection (Amersham Pharmacia Biotech, Orsay, France), then quantified by densitometric analysis using QuantityOne (Biorad, Hercules, CA, USA).
Measurement of RhoA and Rac activities
Activity of RhoA and Rac was analyzed by a pull-down assay using the Rho binding domain of the Rho protein effectors Rhotekin and PAK, respectively [25] . cDNA encoding for the rhotekin and PAK RBD was kindly provided by Dr. Martin Schwartz (University of Virginia, Charlottesville, Virginia). ASMC were serum-starved for 24 h, stimulated or not with HA, then washed with ice-cold PBS and lysed in a lysis buffer (50 mM Tris, pH 7.2, 500 mM NaCl, 10 mM MgCl 2 , 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, protease inhibitor cocktail (Sigma)). After centrifugation 12,000×g at 4°C for 10 min, the extracts were incubated at 4°C for 45 min with glutathione-Sepharose 4B beads coupled with glutathione-S-transferase (GST)-rhotekin RBD fusion protein (for Rho activity) or GST-PAK RBD fusion protein (for Rac activity). Precipitated GTP-bound and total RhoA and Rac were then analyzed by Western blotting using a mouse monoclonal antiRhoA or anti-Rac antibody. Immunoreactive bands were detected using ECL detection and quantified by densitometric analysis.
siRNA
The siRNA sequence targeting rat CD44 (mRNA sequence accession number NM_012924) and RHAMM (mRNA sequence accession number NM_012964) were selected using the software developed by Eurogentec (Seraing, Belgium) and verified in a BLAST search. The sense strand sequences of siRNAs (Eurogentec) used were: CD44, 5′-GAAGGGCGAGUAUAGAACAdTdT-3′; and RHAMM, 5′-AGAGAAGGAUCGUGAGAUUdTdT-3′. To inhibit Rac1 synthesis, we used the following sense strand sequences of siRNA: 5′-GUUCUUAAUUUGCUUUUCCdT dT-3′ [26] . A "universal" scrambled siRNA has been used for control (sense: 5′-CGACUUCCUUACUCUAUACdTdT-3′).
The siRNAs were introduced into ASMC with JetPEI reagent (Polytransfection, Illkirch, France) according to the manufacturer's recommendations. Cells were incubated with or without 1.2 μg of specific or scrambled siRNA for 48 h before functional assays were conducted. The efficiency of siRNA-mediated gene silencing has been assessed by realtime quantitative PCR and Western blot.
Real-time quantitative PCR
Total RNA was extracted from control (scrambled siRNA), CD44 siRNA-and RHAM siRNA-treated ASMC using TRIzol reagent then treated with RNase-free DNase. Total RNA (1 μg) was used as template for the reverse transcriptase (RT) reaction using MMLV, 2 μg random hexamers, 0.5 mM dNTPs and 5 mM DTT (Life Technologies). Real-time quantitative PCR was performed in the iCycler iQ™ Detection System (Bio-Rad Laboratories) using Sybr green detection (Molecular Probes) and Titanium™ Taq DNA polymerase (Clontech), according to the manufacturer's recommendations. The primer pairs used were: CD44 (sense: 5′-TGGATGCGAGGAGGATATACAC; anti-sense: 5′-CTGCGAGGCTTTCAACACC); RHAMM (sense: 5′-TGCCCTGGATGAGCTGGA; anti-sense: 5′- GCATGTGCAGCGGTTCTTT); GAPDH (sense: 5′-TCCATTTACAACCACAACGATTC; anti-sense: 5′-CTGA-GAGGCAAGGATGAATGATT). The following temperature profile was used: 40 cycles of 15 s at 95°C and 1 min at 60°C. Cycle numbers obtained at the log-linear phase of the reaction were plotted against a standard curve prepared with serially diluted control cDNA samples. Expression of target genes was normalized to GAPDH levels. The delta Ct (Cycle threshold) method was used to calculate relative expression levels.
Chemical and drugs
Mouse monoclonal RhoA and Rac antibodies, blocking CD44 antibody (sc-7946) [27] and goat polyclonal RHAMM antibody were purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Rabbit polyclonal anti-phospho-PAK1 and anti-PAK1 antibodies were from Cell Signaling Technology (Ozyme, Saint Quentin, France). Rat monoclonal CD44 antibody was from Chemicon (Hampshire, UK). LY 294002 was purchased from Calbiochem (France Biochem, Meudon, France). The permeant RhoA inhibitor Tat-C3 protein was produced in E. coli and purified as already described [17, 28] . HA from rooster comb was used in this study (Sigma, SaintQuentin Fallavier, France). Its average molecular weight was 2100 kDa [29] . All other reagents were purchased from Sigma (Saint-Quentin Fallavier, France).
Statistics
All results are expressed as the means ± S.E.M. of sample size n. Significance was tested by Student's t-test. Data were considered statically significant when P b 0.05. 
Results
High-molecular weight HA dose-dependently induces ASMC migration but not proliferation
The in vitro model of ASMC monolayer wounding and restitution was first used to assess the effect of high-molecular weight HA on ASMC migration (Fig. 1) . After scrape wounding, ASMC migrated across the wound edge to fill in the area that was denuded of cell by the scrape (Fig. 1A) . Exposure to HA (1-5 mg/ml) resulted in a dose-and timedependent stimulation of ASMC migration, leading to acceleration of the wound closure (Fig. 1A-C) . The HA concentration required to induce 50% of maximal effect (EC50) is closed to 1.8 mg/ml whatever was the time postwounding (Fig. 1C) . In similar experiments, the rate of cell proliferation, determined by cell counting or BrDU incorporation, in migrating and stationary ASMC over the initial 24 h period, was not modified in the presence of HA (data not shown), indicating that the accelerated wound closure induced by HA is proliferation-independent. Similar results have been obtained in Boyden chamber assays.
HA stimulates the actin cytoskeleton organization
Since actin cytoskeleton reorganization is required for cell shape modification and cell migration, we examined the effect of HA on actin cytoskeleton organization in ASMC. Phalloidin staining revealed that HA induced reorganization of actin cytoskeleton at the wounded edge, promoting lamellipodia and actin stress fiber formation (Fig. 2) . This effect was observed from the first hour to up to 24 h post wounding.
HA induces sequential activation of the Rho proteins RhoA and Rac
RhoA and Rac protein activity controls stress fibers and lamellipodia formation, respectively [30] . We therefore next asked whether HA induced RhoA and/or Rac activation in ASMC. The activity of RhoA and Rac was assessed by the detection of the GTP-loaded forms of these proteins by pull down assays. As shown in Fig. 3A , HA transiently activated RhoA in ASMC stimulated with HA for 10 min. RhoA activity returned to basal level after 1 h of HA stimulation. HA also induced a sustained Rac activity, observed at 10 min (Fig. 3B) . Increased Rac activity was maintained up to 6 h (not shown). Our results thus provide evidence that HA-induced migration and actin cytoskeleton reorganization is associated with activation of RhoA and Rac.
Inhibition of Rac prevents HA-induced migration
To determine whether HA-mediated ASMC migration was dependent on Rho protein activity, we analyzed the effects of non-selective and selective Rho inhibitors on ASMC migration. In Boyden chamber assay, the non-selective Rho protein activity inhibitor simvastatin (10 μM) dramatically decreased the migration induced by HA (Fig. 4A) . In contrast, selective inhibition of RhoA or its effector Rho kinase by Tat-C3 (10 μg/ ml) and Y-27632 (10 μM), respectively, did not alter HAinduced ASMC migration (Fig. 4A) . These concentrations of inhibitors efficiently inhibited RhoA/Rho kinase-dependent functions in ASMC [17] . To further investigate the signaling pathways involved in HA-induced ASMC migration, we next assessed the effect of inhibition of Rac by the Clostridium sordellii lethal toxin (LT-toxin) and by siRNA targeting Rac. When ASMC were treated with LT-toxin (1 μg/ml), HAinduced migration was almost totally inhibited (Fig. 4B) . Similarly, Rac siRNA, that produced a 60% depletion of Rac protein (48 h, not shown), efficiently inhibited HA-induced migration (Fig. 4B) . PI3K inhibition by LY-294002 (25 μM; Fig. 4B ) or wortmanin (100 nM, not shown) also significantly decreased HA-mediated ASMC migration. Scratch-wound repair assays gave similar results. These results thus provide evidence that RhoA and Rho kinase activity are not involved in the effect of HA but that Rac and PI3K activation are required for HA-mediated migration.
RHAMM knockdown inhibits HA induced ASMC migration
Both CD44 and RHAMM are established signal-transducing receptors that influence several cell functions, including cell motility [7] . We therefore analyzed the ability of CD44 function-blocking antibody and siRNA targeting RHAMM and CD44, to prevent HA-induced ASMC migration. The efficiency and the selectivity of siRNA targeting RHAMM and CD44 have been assessed by real time RT-PCR. After 48 h, siRNA targeting CD44 decreased the expression of CD44 mRNA expression by 88.0 ± 2.0% (n = 3) without effect on RHAMM mRNA. Similarly, siRNA targeting RHAMM decreased the expression of RHAMM mRNA expression by 52 ± 10% (n = 3), without effect on CD44 mRNA level. At protein level, siRNA targeting CD44 and RHAMM induced a 60-70% decrease in CD44 and RHAMM expression, respectively (Fig. 5A) .
In wound-healing assay, HA-induced ASMC motility was not modified by treatment within CD44 blocking antibody (10 μg/ml) or by siRNA targeting CD44 (Fig. 5B, C) . Boyden chamber migration assays confirmed the absence of effect of CD44 blocking antibody and CD44 siRNA on HA-induced ASMC migration (Fig. 5D) . In contrast, both HA-stimulated wound closure and HA-induced migration in Boyden chamber assay were significantly inhibited in RHAMM siRNA-treated ASMC (Fig. 5B-D) . These data thus provide evidence that CD44 is not involved in HA-mediated ASMC migration and that only RHAMM is required for HAmediated ASMC motility.
HA-induced Rac activation is mediated by RHAMM
Both Rac and RHAMM are required for HA-induced migration. We therefore hypothesized that stimulation of Rac activity is mediated by HA-induced RHAMM activation, while activation of RhoA would involve CD44. To assess this hypothesis, we therefore performed pull-down assay of RhoA and Rac activity in the absence and presence of siRNA targeting CD44 and RHAMM. As shown in Fig. 6A , siRNA targeting CD44 inhibited HA-induced RhoA activation by 61 ± 7% at 10 min (n = 3, P b 0.001), without any effect on Rac activity. In contrast, siRNA targeting RHAMM decreased HA-mediated Rac activation by 67 ± 6% (n = 3, P b 0.001), but did not affect RhoA activation (Fig. 6A) . These findings indicate that stimulation of RhoA and Rac activity by HA is independently mediated by CD44 and RHAMM activation, respectively.
HA-induced Rac activation is dependent of PI3K
The inhibition of PI3K prevented HA-induced ASMC migration. We therefore assessed whether PI3K is involved in HA-mediated activation of Rac signaling pathway in ASMC. HA-induced activation of Rac signaling was monitored by measuring both the amount of GTP-bound Rac, and the level of activation/phosphorylation of the Rac target PAK in the absence and presence of the PI3K inhibitor LY-294002. Pulldown assay and western blot analysis show that HA-induced Rac and PAK activation was inhibited by LY-294002 (25 μM) (Fig. 6B) or wortmannin (100 nM, not shown). These results indicate that activation of Rac by HA-mediated stimulation of RHAMM is a PI3K-dependent process.
Discussion
Despite several observations have suggested a major role for HA in the development of atherosclerosis and restenosis, little is known about the signaling pathways responsible for HA effects in ASMC. Herein, we demonstrate that highmolecular weight HA leads to independent activation of the actin cytoskeleton-regulating proteins RhoA and Rac through CD44 and RHAMM, respectively. ASMC migration induced by HA stimulation depends exclusively on RHAMM-mediated PI3K-dependent Rac activation.
In normal physiological conditions, HA consists of 2000-25,000 disaccharides, which corresponds to polysaccharides with relative mass of 1-10· 10 6 Da [7] . Biological HA effects have been reported to depend on HA molecular mass [31, 32] .
Here we addressed the effect of HA of approximately 2·10 6 Da, typically found in injured arterial walls [33] . Although it is not possible to correlate the concentrations used with the in vivo physiological or pathological HA concentrations, the effective HA concentrations inducing ASMC migration (EC50∼ 1.8 mg/ml) corresponded to active concentrations typically reported for high-molecular weight rooster comb HA, that ranged between 0.1 and 4.0 mg/ml [29, [34] [35] [36] .
It is recognized that migration of ASMC from the media plays a central role in progressive intimal thickening leading to arteriosclerosis or restenosis after arterial injury [37] . ASMC motility could be altered not only by several soluble factors but also by ECM proteins [38] . There is increasing evidence that HA facilitates ASMC locomotion [4] . Several mechanisms could participate to HA-induced ASMC motility. Around ASMC, formation of dynamic HA-and versicanrich pericellular matrix facilitates migration by diminishing cell surface adhesion and affecting cell shape [3] . HA also regulates cell motility through interaction with cell surface receptors such as CD44 and RHAMM, and activation of downstream intracellular signaling. The HA binding to CD44 affects cell adhesion to ECM components and is implicated in the stimulation of aggregation, proliferation, migration, and angiogenesis [8] . HA binding to CD44 regulates interaction of the cytoplasmic domain of CD44 with tyrosine kinases and with the cytoskeleton, and modulates the activity of the Rho proteins RhoA and Rac1 [20, 22] . Activation of RhoA and its downstream effector Rho kinase by HA binding to CD44 has been proposed to be necessary for membrane-cytoskeleton interactions and tumor cell migration during the progression of breast cancers [22] . Selective interaction of the CD44 cytoplasmic domain with Rho protein guanine nucleotide exchange factors (p115RhoGEF, Tiam1, and Vav2) has been shown to play an important role in HA-mediated tumor cell migration [8, 39] . In addition, regulation of Cdc42-cytoskeleton interaction by HA-CD44 binding is involved in ovarian tumor progression [40] . It is important to mention that the most part of studies analyzing intracellular signaling pathways coupling HA receptors to HA-mediated effects has been performed in transformed/tumor cells, and therefore probably cannot be extended to untransformed/normal cells. In this study, we demonstrate that in ASMC, HA induces activation of RhoA and Rac. However, siRNA-mediated HA receptor knockdown and blocking antibody indicate that only RhoA activation is mediated by CD44 and that, contrary to results obtained in tumor cells, this signaling pathway is not involved in HA-induced ASMC migration under our experimental conditions. Our observation is however in agreement with previous reports showing the major role of RHAMM in HA-stimulated migration of untransformed vascular cells, such as bovine aortic smooth muscle cells [4] , and endothelial cells [41] . The varied role of CD44 in HAinduced cell migration may thus be attributable to differences in experimental design but other obvious differences include cell type (untransformed versus transformed), cell origin, cell passage, animal species, HA origin and size.
The role of HA-CD44-mediated RhoA activation has not been investigated here. However, our data suggest that this signaling pathway does not stimulate ASMC proliferation. As RhoA is a key regulator of ASMC contraction, CD44-mediated RhoA activation could induce ASMC contraction, which could participate to the previously described HAinduced enhancement of collagen contraction by ASMC [42] . This hypothesis is supported by (i) the observation of HAinduced stimulation of actin stress fiber formation, which is a RhoA-dependent phenomenon associated to cell contraction [11] , and (ii) the inhibition of HA-induced stress fibers in cells treated with siRNA targeting CD44 (not shown).
Our results do not reveal a role for HA in the regulation of vascular smooth muscle cell proliferation. Although high concentrations of HA of unknown size have been reported to stimulate DNA synthesis in vascular smooth muscle cells [43] , similarly to our results, high molecular weight HA applied for 24 h had no effect on aortic smooth muscle cells from monkey [42] . Very recently, fragmented, but not high molecular weight HA (N2 · 10 6 Da) has been shown to stimulate rat aortic smooth muscle cell proliferation in inverse correlation with fragment size [44] .
Although RHAMM is identified as microtubule-associated protein that interacts with actin [8, 10] , the molecular bases of RHAMM-mediated cell motility are not clearly identified. Here we show that in ASMC, HA-RHAMM interaction activates Rac and that Rac activation is required for HAmediated ASMC motility. To our knowledge, this is the first demonstration of the involvement of Rho protein in intracellular signaling downstream of RHAMM. An essential role of Rac in cell migration has been established in a large variety of cell types [45, 46] . Rac is important for the formation of lamellipodia at the leading edge of the cells and forward movement, and is also involved in cell retraction at the trailing edge via its effector PAK. The observation that HA induced lamellipodia formation in ASMC is therefore in agreement with Rac-mediated cytoskeletal rearrangement and migration in response to HA. Inhibition of Rac by LT-toxin and siRNA targeting Rac almost completely prevented HA-induced ASMC migration indicating that Rac activation is a critical step in the intracellular pathway activated by HA-RHAMM mediating cell motility.
Results obtained with LY-294002 show that activation of PI3K is required for HA to stimulate ASMC motility. Furthermore, the analysis of Rac/PAK activation by HA indicated that PI3K is upstream to Rac activation. PI3Ks lipid products have been widely implicated in controlling cell migration and polarity [47, 48] . The production of PI(3,4,5)P 3 has been shown to lead to an increase in GTP-bound Rac in many cell types. The mechanism by which this lipid promotes GTP loading on Rac is thought to be through a direct interaction with Rac exchange factors. All members of the Dbl family of Rho protein exchange factor contain a pleckstrin homology domain and at least some of these can bind phospholipids. Tiam, PIX and Vav have been shown to be activated by PI (3,4,5)P 3 [47, 49] . It is therefore likely that HA-induced PI3K-dependent Rac activation and migration occurred through the activation of a PI(3,4,5)P 3 -dependent exchange factor.
Previously, drugs such as paclitaxel have been used to inhibit ASMC proliferation in in-stent restenosis by acting on the cytoskeleton [50] . Our results, showing that RHAMM-associated PI3K/Rac signaling is responsible for HA-induced actin cytoskeleton remodeling and cell migration might represent a new signaling pathway that could participate to the development of in-stent restenosis.
